Pulmonary fibrosis - Symptoms and causes - Mayo Clinic
Feb 15, 2024 · Pulmonary fibrosis with no known cause is called idiopathic pulmonary fibrosis. Many people with idiopathic pulmonary fibrosis also may have gastroesophageal reflux disease, also called …
Pulmonary fibrosis - Diagnosis and treatment - Mayo Clinic
Feb 15, 2024 · If you have idiopathic pulmonary fibrosis, your healthcare professional may recommend the medicine pirfenidone (Esbriet) or nintedanib (Ofev). Both are approved by the U.S. Food and …
Anti-fibrotic therapy in the treatment of IPF: Ongoing concerns and ...
While multiple trials assessing different mechanisms and approaches to treatment have proved negative over the past decade and a half, two drug therapies have recently become available for the directed …
Pulmonary fibrosis care at Mayo Clinic
Feb 15, 2024 · Doctors at Mayo Clinic do research and use novel therapies to treat pulmonary fibrosis and related conditions. Mayo Clinic offers the latest medicines to treat idiopathic pulmonary fibrosis, …
Idiopathic Pulmonary Fibrosis: Any clinical trial recommendations?
May 4, 2025 · Are you getting oxygen therapy, pulmonary breathing therapy/breathing support treatments and physical/occupational therapy? You may want to see a dietitian/nutritionist to review …
Interstitial lung disease - Symptoms and causes - Mayo Clinic
Nov 23, 2024 · Idiopathic pulmonary fibrosis, also called IPF. IPF is a typically progressive lung disease that occurs when lung tissue becomes damaged and scarred — what's known as fibrosis.
Updates in interstitial lung disease: Current facets of anti-fibrotic ...
Oct 18, 2019 · Teng Moua, M.D., discusses recent clinical trials and current research into the treatment of idiopathic pulmonary fibrosis (IPF) and non-IPF-progressive interstitial lung diseases.
肺纤维化 - 症状与病因 - 妙佑医疗国际 - Mayo Clinic
May 24, 2024 · Raghu G, et al. Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: An official ATS/ERS/JRS/ALAT clinical practice guideline.
Nintedanib (oral route) - Side effects & dosage - Mayo Clinic
6 days ago · Description Nintedanib is used to treat idiopathic pulmonary fibrosis. It helps prevent changes to the lung tissue. It is also used to treat people with a chronic (long-lasting) interstitial lung …
Interstitial lung disease - Diagnosis and treatment - Mayo Clinic
Nov 23, 2024 · Medicines that slow the worsening of idiopathic pulmonary fibrosis. Pirfenidone (Esbriet) and nintedanib (Ofev) are medicines that may slow the rate at which IPF worsens.